Possible Audits

As we come up with ideas for possible audits, I will accumulate them.

• If there are multiple biosources for a biosample check for a protocol for the biosample.
• Do they have a vendor that is just written differently but refers to an existing one
• Files can accept multiple experiments, however raw files (at least currently) should come from a single experiment. We can have an audit for this, at least to have information how people make use of this in raw files.
• Biological replicates and Technical replicates should be checked if they carry the finalized DCIC definition. Also for experiments submitted together, we should check if there are any experiments that can be technical/ biological replicates but not indicates so.
• if there are multiple biosources in biosample, the frond end rendering will ignore the second one in calculated properties, for example for naming. We do not expect multiple biosources, and we should know if there are any such cases.
• tier 1 cells 10 passages require karyotype image
• make sure same file is not in an experiment twice, or raw files are associated with a single experiment